Skip to main content

Efavirenz/Emtricitabine/Tenofovir (Efavirenz/Emtricitabine/Tenofovir) Shopper Approved

Prescription Prescription Required FormationFormulation: Tablet

Efavirenz/Emtricitabine/Tenofovir

We don't sell this brand-version medication.

  *  
Prescription Prescription Required FormationFormulation: Tablet

Efavirenz/Emtricitabine/Tenofovir

(Generic Alternative)

Select the prescribed dosage

Select the quantity to see the price.

  *  
delivery

* This price includes a dispensing fee, medical review fee, and packing fee.

delivery

Shipped and delivered directly to your doorstep

Efavirenz/emtricitabine/tenofovir is a prescription medication used to treat human immunodeficiency virus type 1 (HIV-1) infection in adults and certain pediatric patients.

This medication contains three active ingredients: efavirenz, emtricitabine, and tenofovir disoproxil fumarate. These medicines work together to prevent HIV from multiplying, lower the amount of virus in the blood, and help protect the immune system.

HIV is a virus that attacks the immune system, particularly CD4 cells, which are white blood cells that help your body fight infections. Over time, untreated HIV can damage these cells and weaken your body’s ability to protect itself against infections and certain diseases.

Without effective treatment, HIV infection may progress to acquired immunodeficiency syndrome (AIDS), the most advanced stage of HIV infection.

Efavirenz/eEmtricitabine/tenofovir is a medication that belongs to a group of medications called antiretroviral drugs. Antiretroviral therapy (ART) helps control HIV by preventing the virus from making new copies of itself.

When taken consistently as prescribed, this medication can lower the amount of HIV in your bloodstream to very low levels, often becoming undetectable on standard viral load tests.

Although efavirenz/emtricitabine/tenofovir does not cure HIV, it can help people living with HIV maintain better immune system health and reduce the risk of serious HIV-related complications.

Treatment of HIV-1 Infection

Efavirenz/emtricitabine/tenofovir is used to treat HIV-1 infection in eligible adults and pediatric patients.

It combines three antiretroviral medicines in a single tablet, which may make daily treatment more convenient for people who are prescribed this combination.

Your healthcare provider will determine whether this medication is appropriate based on your age, body weight, medical history, kidney and liver function, previous HIV treatments, and the results of HIV resistance testing.

Efavirenz/Emtricitabine/Tenofovir helps manage HIV infection in several important ways:

  • Lowers Viral Load: The medication prevents HIV from multiplying, reducing the amount of virus circulating in your blood. A lower viral load helps protect your immune system and reduces the risk of HIV-related complications.
  • Protects Immune System Function: By controlling HIV replication, the medication helps preserve CD4 cells, which play an important role in fighting infections. Over time, successful treatment may allow CD4 cell counts to improve.
  • Reduces the Risk of HIV-Related Illnesses: Keeping HIV under control helps lower the risk of opportunistic infections and other health problems that are more likely to develop when the immune system becomes severely weakened.
  • Helps Prevent HIV Disease Progression: Consistent antiretroviral treatment reduces the likelihood of HIV progressing to AIDS and supports better long-term health.
  • Supports Long-Term HIV Management: Maintaining a low or undetectable viral load can help people living with HIV remain healthier and continue their everyday activities.
  • Reduces the Risk of HIV Transmission: People living with HIV who take antiretroviral treatment and maintain a sustained undetectable viral load do not transmit HIV through sex. This is known as Undetectable = Untransmittable (U=U).

Efavirenz/Emtricitabine/Tenofovir must be taken regularly to maintain effective control of HIV.

Missing doses or stopping treatment can allow the virus to multiply again and may increase the risk of developing resistance to HIV medications.

Your healthcare provider will monitor your viral load, CD4 cell count, and overall health to determine how well your treatment is working.

Important: Efavirenz/Emtricitabine/Tenofovir is a treatment for established HIV-1 infection. It should not be used on its own as pre-exposure prophylaxis (PrEP) or post-exposure prophylaxis (PEP).

How Does Efavirenz/Emtricitabine/Tenofovir Work?

Efavirenz/Emtricitabine/Tenofovir contains three antiretroviral medications that work together to stop HIV from making new copies of itself.

To multiply inside the body, HIV enters certain immune cells and uses an enzyme called reverse transcriptase to convert its genetic material into DNA.

This is an essential step in the HIV life cycle because it allows the virus to establish infection within cells and continue reproducing.

All three active ingredients interfere with reverse transcriptase, but they do so in different ways.

By combining medications with complementary mechanisms, Efavirenz/Emtricitabine/Tenofovir helps suppress HIV replication and maintain a lower viral load.

Efavirenz: Blocks HIV Reverse Transcriptase

Efavirenz belongs to a class of antiretroviral medications called non-nucleoside reverse transcriptase inhibitors (NNRTIs).

It works by attaching directly to the HIV reverse transcriptase enzyme and changing how the enzyme functions.

When reverse transcriptase cannot work properly, HIV has difficulty converting its genetic material into DNA. This interferes with the virus’s ability to establish new infections within cells.

Efavirenz helps to:

  • Block Viral Replication: Prevents reverse transcriptase from functioning normally, making it harder for HIV to reproduce.
  • Reduce Viral Activity: Helps decrease the production of new HIV copies.
  • Support Viral Suppression: Works with the other ingredients to maintain a low viral load.

Efavirenz acts differently from emtricitabine and tenofovir, allowing the three medications to work together against HIV.

Emtricitabine: Interrupts HIV DNA Production

Emtricitabine belongs to a class of medications called nucleoside reverse transcriptase inhibitors (NRTIs).

It works by interfering with the process HIV uses to create DNA from its genetic material.

When emtricitabine is incorporated into the developing viral DNA chain, it prevents the chain from being completed. This interrupts HIV replication.

Emtricitabine helps to:

  • Prevent HIV From Making New Copies: Interrupts an essential step in the virus’s reproductive process.
  • Reduce Viral Load: Helps lower the amount of HIV circulating in the bloodstream.
  • Protect Immune Function: Supports the preservation of immune cells by helping control HIV activity.

When combined with efavirenz and tenofovir, emtricitabine contributes to effective HIV suppression.

Tenofovir Disoproxil Fumarate: Prevents Viral DNA Formation

Tenofovir disoproxil fumarate (TDF) is a medication that the body converts into tenofovir.

Tenofovir belongs to a group of antiretroviral medications called nucleotide reverse transcriptase inhibitors. It is generally included within the broader NRTI medication class.

Like emtricitabine, tenofovir works by interfering with the formation of HIV DNA.

After being activated inside cells, tenofovir blocks the reverse transcriptase enzyme’s ability to complete the viral DNA chain.

Tenofovir helps to:

  • Interrupt HIV Replication: Prevents the virus from completing an important step required to make new copies.
  • Lower Viral Load: Works with the other ingredients to reduce the amount of HIV in the body.
  • Support Long-Term Viral Suppression: Helps maintain control of HIV when taken consistently.

Tenofovir disoproxil fumarate can affect kidney function and bone health in some patients. Your healthcare provider may recommend monitoring your kidney function and assessing your bone health when appropriate.

How Do the Three Ingredients Work Together?

Efavirenz, emtricitabine, and tenofovir disoproxil fumarate work together to prevent HIV from multiplying.

Efavirenz blocks the action of the reverse transcriptase enzyme directly, while emtricitabine and tenofovir interfere with the formation of viral DNA.

Although all three medications target HIV reverse transcription, they interfere with the process in different ways.

This combination helps:

  • Reduce the amount of HIV in your bloodstream.
  • Maintain an undetectable viral load when treatment is successful.
  • Protect CD4 cells and support immune system recovery.
  • Lower the risk of HIV-related illnesses.
  • Reduce the risk of HIV developing resistance when the medication is taken correctly.

Combining three active ingredients in one tablet can simplify treatment for eligible patients by reducing the number of separate medications they need to take each day.

However, the combination may not be suitable for everyone. Your healthcare provider will consider potential drug interactions, medication resistance, and your overall health before prescribing it.

Important Information About Efavirenz/Emtricitabine/Tenofovir

Efavirenz/Emtricitabine/Tenofovir is intended for the treatment of HIV-1 infection in adults and eligible pediatric patients weighing at least 40 kg, according to U.S. prescribing information.

The usual dose of the fixed-dose combination containing efavirenz 600 mg, emtricitabine 200 mg, and tenofovir disoproxil fumarate 300 mg is one tablet once daily on an empty stomach, preferably at bedtime. Taking it at bedtime may help reduce certain nervous system side effects, such as dizziness and unusual dreams. 

Before starting treatment, tell your healthcare provider if you have kidney disease, liver disease, hepatitis B, depression, or a history of seizures. Your healthcare provider should also review your other medications for possible interactions.

Hepatitis B precaution: If you have both HIV and hepatitis B, stopping this medication may cause a serious worsening of hepatitis B. Do not discontinue treatment without medical supervision. 

Your healthcare provider will recommend regular blood tests to monitor your viral load, immune system health, kidney function, and overall response to treatment.

Even if your viral load becomes undetectable, continue taking evafereniz/emtricitabine/tenofovir exactly as prescribed. Stopping treatment or frequently missing doses can allow HIV to multiply again and may lead to drug resistance.

Efavirenz/emtricitabine/tenofovir helps control HIV-1 infection by preventing the virus from multiplying and protecting your immune system. Taking the medication consistently and attending regular medical appointments can support long-term viral suppression and better overall health.

Efavirenz/emtricitabine/tenofovir is a prescription antiretroviral medication used to treat human immunodeficiency virus type 1 (HIV-1) infection. It contains three active ingredients that work together to prevent HIV from multiplying, lower the amount of virus in your blood, and help protect your immune system.

The medication is available as an oral tablet and is usually taken once daily on an empty stomach, preferably at bedtime.

Taking efavirenz/emtricitabine/tenofovir at bedtime may help reduce the impact of certain side effects associated with efavirenz, including dizziness, drowsiness, difficulty concentrating, and unusual dreams.

Because this medication contains fixed amounts of efavirenz, emtricitabine, and tenofovir disoproxil fumarate, your healthcare provider will determine whether the combination is appropriate for your HIV treatment.

Always follow your prescribed dosage and treatment schedule carefully.

Recommended Dosage of Efavirenz/Emtricitabine/Tenofovir

The standard fixed-dose combination tablet contains:

  • Efavirenz 600 mg: Helps block an enzyme HIV needs to reproduce.
  • Emtricitabine 200 mg: Prevents HIV from completing the production of new viral DNA.
  • Tenofovir disoproxil fumarate 300 mg: Works with the other ingredients to prevent HIV replication.

The usual recommended dose for eligible adults and adolescents weighing at least 40 kg is one tablet taken by mouth once daily.

Your healthcare provider will consider your body weight, kidney function, liver health, medical history, previous HIV treatments, and possible drug interactions before prescribing the medication.

Because all three medications are combined into a single tablet, the dosage of each ingredient cannot be adjusted separately.

If you require a different dose of one of the active ingredients, your healthcare provider may recommend another HIV treatment regimen.

Do not change your dosage or take additional tablets without medical advice.

How to Take Efavirenz/Emtricitabine/Tenofovir Tablets

Follow these steps to take Efavirenz/Emtricitabine/Tenofovir safely and correctly:

  1. Check your prescribed dosage: Make sure you understand how many tablets to take and when to take them. The usual dosage is one tablet once daily, but always follow your healthcare provider’s instructions.
  2. Take the medication on an empty stomach: Avoid taking the tablet with food, particularly high-fat meals, because food can increase efavirenz absorption and may worsen certain side effects.
  3. Take it at bedtime: Taking the medication before going to sleep may help reduce the impact of dizziness, drowsiness, and unusual dreams that can occur with efavirenz.
  4. Swallow the tablet with water: Take the tablet by mouth with a glass of water. Swallow it whole unless your healthcare provider or pharmacist has provided specific alternative instructions.
  5. Take it at the same time each day: Choose a regular bedtime that works with your schedule. Taking the medication consistently helps maintain effective drug levels in your body.
  6. Continue treatment every day: Take Efavirenz/Emtricitabine/Tenofovir as prescribed, even if you feel healthy or your viral load has become undetectable.

Important Tips When Taking Efavirenz/Emtricitabine/Tenofovir

Take the Medication on an Empty Stomach

Efavirenz/eEmtricitabine/tenofovir should generally be taken without food.

Taking the medication with food, especially a high-fat meal, can increase the amount of efavirenz absorbed into your bloodstream. This may increase your risk of side effects such as dizziness, drowsiness, nausea, and unusual dreams.

Taking the tablet at bedtime on an empty stomach may help make these effects easier to manage.

Ask your pharmacist for guidance if you are unsure how to schedule your dose around your evening meals.

Take Your Dose at Bedtime

Efavirenz may cause nervous system side effects, particularly during the first few weeks of treatment.

These may include dizziness, difficulty concentrating, sleep disturbances, vivid dreams, or feeling unusually tired.

Taking evafereniz/emtricitabine/tenofovir at bedtime may reduce how much these symptoms interfere with your daily activities.

Some side effects improve as your body adjusts to the medication. However, persistent or severe symptoms should be reported to your healthcare provider.

Avoid driving, operating machinery, or performing activities that require full alertness if the medication makes you dizzy or drowsy.

Take Your Medication Every Day

Consistent treatment is essential for keeping HIV under control.

Efavirenz/emtricitabine/tenofovir works by interfering with HIV replication. When taken regularly, it helps reduce the amount of HIV in your blood and maintain viral suppression.

Missing doses can allow the virus to multiply again, increasing your viral load and potentially weakening your immune system.

Frequent missed doses may also allow HIV to develop resistance to one or more of the medications.

Drug-resistant HIV can be more difficult to treat and may limit the effectiveness of certain antiretroviral medications in the future.

To help maintain consistent treatment, take your tablet at approximately the same time every day.

Do Not Change Your Dosage

Do not increase or decrease your dose of efavirenz/emtricitabine/tenofovir without consulting your healthcare provider.

Taking more medication than prescribed may increase your risk of serious side effects.

Taking less than prescribed may reduce viral suppression and increase the risk of drug resistance.

Because this medication combines three active ingredients in a single tablet, dosage adjustments may require switching to a different HIV treatment regimen.

Your healthcare provider will determine whether any changes are necessary based on your viral load, medical history, laboratory results, and response to treatment.

Do Not Stop HIV Treatment Without Medical Advice

Continue taking efavirenz/emtricitabine/tenofovir even if you feel well or your HIV viral load becomes undetectable.

An undetectable viral load means the amount of HIV in your blood is too low to be measured by standard viral load tests. However, HIV remains present in your body.

Stopping antiretroviral treatment can allow the virus to multiply again, causing your viral load to increase.

If you experience side effects or have difficulty taking your medication, contact your healthcare provider before stopping treatment.

Your healthcare provider may be able to recommend ways to manage side effects or consider a different HIV treatment regimen.

Important: If you also have hepatitis B, stopping this medication may cause a serious worsening of your hepatitis B infection. Do not discontinue treatment without medical supervision.

What Should I Do If I Miss a Dose?

If you forget to take efavirenz/emtricitabine/tenofovir, take the missed dose as soon as you remember, unless it is almost time for your next scheduled dose.

If your next dose is approaching, skip the missed tablet and continue with your regular treatment schedule.

Do not take two tablets at once or double your next dose to make up for a missed tablet.

Because missing HIV medication can increase the risk of viral replication and drug resistance, contact your healthcare provider or pharmacist if you are uncertain what to do.

If you frequently forget doses, consider setting a daily reminder, using a medication tracking app, or discussing adherence strategies with your healthcare team.

Why Is Taking Every Dose Important?

Taking your HIV medication consistently is one of the most important parts of successful HIV treatment.

Efavirenz/emtricitabine/tenofovir helps prevent HIV from making new copies of itself. Maintaining enough medication in your bloodstream is essential for keeping the virus suppressed.

If you frequently skip doses, change your dosage, or interrupt treatment, HIV may begin multiplying again.

This can cause your viral load to increase and may eventually reduce your immune system’s ability to fight infections.

Inconsistent treatment can also increase the risk of developing drug-resistant HIV. When resistance develops, certain HIV medications may no longer work as effectively.

Taking your medication every day as prescribed helps maintain viral suppression, protect immune function, and reduce the risk of HIV-related complications.

Ongoing HIV Treatment and Monitoring

Efavirenz/emtricitabine/tenofovir is intended for ongoing treatment of HIV-1 infection.

Your healthcare provider will recommend regular follow-up appointments and laboratory tests to monitor your response to treatment.

These may include:

  • HIV Viral Load Testing: Measures the amount of HIV in your blood to determine whether treatment is effectively suppressing the virus.
  • CD4 Cell Count: Helps assess the health of your immune system and how well it is recovering during treatment.
  • Kidney Function Tests: Monitor your kidney health because tenofovir disoproxil fumarate may affect kidney function in some patients.
  • Liver Function Tests: Help identify possible liver-related side effects, especially if you have existing liver disease or viral hepatitis.
  • Other Health Assessments: Your healthcare provider may review your bone health, mental health, other medications, and any side effects you experience.

Your healthcare provider will determine how frequently these tests are needed based on your medical history and treatment response.

When to Contact Your Healthcare Provider

Contact your healthcare provider if you experience persistent dizziness, severe sleep disturbances, unusual mood changes, or other side effects that interfere with your daily activities.

You should also seek medical advice if you have difficulty taking your medication consistently, frequently miss doses, or are considering starting another prescription or over-the-counter medication.

Efavirenz can sometimes cause serious mental health effects, including severe depression, unusual behavior changes, or suicidal thoughts. Contact your healthcare provider promptly if you notice concerning changes in your mood or behavior.

Seek emergency medical attention if you develop signs of a severe allergic reaction, a widespread blistering skin rash, severe confusion, or thoughts of harming yourself that put you in immediate danger.

Always take efavirenz/emtricitabine/tenofovir exactly as prescribed. Taking one tablet daily on an empty stomach, preferably at bedtime, maintaining a consistent treatment schedule, and attending regular medical appointments can help keep HIV under control while reducing the risk of complications.

Common Side Effects of Efavirenz/Emtricitabine/Tenofovir:

  • Abnormally happy mood
  • Confusion
  • Darkening of skin color, especially on the palms of the hands or the soles of the feet
  • Diarrhea
  • Difficulty falling asleep or staying asleep
  • Feeling agitated, worried, or nervous
  • Forgetfulness
  • Gas
  • Headache
  • Indigestion
  • Itching
  • Joint or back pain
  • Pale skin
  • Unusual dreams

Serious Side Effects of Efavirenz/Emtricitabine/Tenofovir:

  • Extreme tiredness
  • Fast or irregular heartbeat
  • Feeling dizzy or lightheaded
  • Flu-like symptoms
  • Hoarseness
  • Increased thirst
  • Light-colored bowel movements
  • Loss of appetite
  • Muscle pain
  • Muscle pain or weakness
  • Nausea
  • Numbness, burning, or tingling in the hands, arms, feet, or legs
  • Ongoing or worsening bone pain
  • Pain in the arms, hands, feet, or legs
  • Pain in the upper right part of the stomach
  • Peeling, blistering, or shedding skin
  • Rash
  • Seizures
  • Shortness of breath or fast breathing
  • Stomach pain
  • Swelling of the face, throat, tongue, lips, eyes, legs, ankles, or feet
  • Unusual bleeding or bruising
  • Urinating large amounts
  • Vomiting
  • Weakness
  • Yellowing of skin or eyes

Efavirenz/Emtricitabine/Tenofovir is available in the following forms and strength:

Efavirenz/Emtricitabine/Tenofovir: Tablet

  • 600/200/300 mg

Before taking efavirenz/emtricitabine/tenofovir, tell your healthcare provider about any medical conditions, allergies, or medications you are taking.

Efavirenz/emtricitabine/tenofovir is a prescription antiretroviral medication used to treat human immunodeficiency virus type 1 (HIV-1) infection. It contains three active ingredients that work together to prevent HIV from multiplying, lower viral load, and help protect your immune system.

Although this medication can effectively control HIV infection, it may cause serious side effects in some people, particularly those with certain pre-existing medical conditions.

Tell your healthcare provider if you have liver disease, kidney disease, osteoporosis, depression, or other significant health concerns before starting treatment.

Your healthcare provider may recommend regular blood tests, medical appointments, and additional monitoring to make sure the medication remains safe and effective.

Lactic Acidosis

In rare cases, evafereniz/emtricitabine/tenofovir may cause a serious condition called lactic acidosis.

Lactic acidosis occurs when too much lactic acid builds up in your bloodstream. This can affect how your organs function and may become life-threatening if not treated promptly.

Emtricitabine and tenofovir disoproxil fumarate, two of the active ingredients in this medication, belong to a group of drugs that have been associated with lactic acidosis.

Possible warning signs include:

  • Unusual muscle pain or weakness: You may experience muscle discomfort or weakness without an obvious cause.
  • Difficulty breathing: You may feel short of breath or begin breathing faster than normal.
  • Severe tiredness: You may feel extremely weak or exhausted, even after resting.
  • Dizziness: You may feel lightheaded, faint, or unusually unsteady.
  • Stomach pain: You may experience persistent abdominal discomfort.
  • Nausea or vomiting: You may feel sick to your stomach or vomit repeatedly.

Lactic acidosis can develop gradually or become serious quickly.

Seek emergency medical attention immediately if you experience severe or unusual symptoms that may indicate lactic acidosis.

Your healthcare provider will determine whether treatment needs to be interrupted and whether additional medical tests are necessary.

Liver Problems

Efavirenz/Emtricitabine/Tenofovir may cause liver problems, including liver inflammation, abnormal liver function tests, and, in rare cases, severe liver damage or liver failure.

Your liver helps process medications and remove harmful substances from your body. If you already have liver disease, your risk of complications may be higher.

Tell your healthcare provider if you have hepatitis B, hepatitis C, cirrhosis, elevated liver enzymes, or another liver condition.

However, serious liver problems have also been reported in people without a previous history of liver disease.

Possible symptoms include:

  • Yellowing of your skin or eyes: This may be a sign of jaundice.
  • Dark urine: Your urine may become noticeably darker than usual.
  • Persistent nausea or vomiting: You may experience ongoing stomach discomfort.
  • Severe abdominal pain: You may notice pain or tenderness, especially in the upper right side of your abdomen.
  • Unusual tiredness: You may feel significantly weaker or more exhausted than normal.
  • Loss of appetite: You may notice a sudden or persistent decrease in your desire to eat.

Your healthcare provider will generally recommend liver function tests before starting treatment and periodically while you are taking the medication.

Efavirenz/emtricitabine/tenofovir is not recommended for people with moderate or severe liver impairment.

Contact your healthcare provider immediately if you notice symptoms of liver problems. Severe symptoms require urgent medical evaluation.

Hepatitis B and Stopping Treatment

If you have both HIV-1 infection and hepatitis B, it is especially important not to stop evairenz/emtricitabine/tenofovir without medical supervision.

Emtricitabine and tenofovir disoproxil fumarate are active against hepatitis B virus as well as HIV.

If these medications are stopped, hepatitis B may become active again or worsen significantly. This is called an acute exacerbation of hepatitis B.

In some cases, a hepatitis B flare-up can cause serious liver damage.

Your healthcare provider should check your hepatitis B status before treatment and may recommend additional monitoring if you have both infections.

If your HIV treatment needs to be changed or discontinued, your healthcare provider will determine how to maintain appropriate hepatitis B treatment.

Do not stop taking efavirenz/emtricitabine/tenofovir on your own. People with HIV and hepatitis B may need close liver monitoring for several months after discontinuation. 

Depression and Mood Changes

Efavirenz, one of the active ingredients, may cause mental health side effects in some people.

These effects may include depression, anxiety, unusual mood changes, difficulty sleeping, agitation, or changes in behavior.

More serious psychiatric reactions, including suicidal thoughts and behavior, have also been reported.

The risk may be greater in people with a history of depression or other mental health conditions, although these reactions can also occur in people without a previous diagnosis.

Tell your healthcare provider if you have experienced depression, anxiety, bipolar disorder, suicidal thoughts, or another mental health condition.

Warning signs may include:

  • Worsening depression: You may experience increased sadness, hopelessness, or loss of interest in everyday activities.
  • Increased anxiety or agitation: You may feel unusually nervous, restless, or irritable.
  • Sleep disturbances: You may experience severe insomnia, nightmares, or unusual dreams.
  • Unusual thoughts or behavior: You may notice significant changes in how you think, feel, or act.
  • Thoughts of self-harm: You may develop new or worsening thoughts about hurting yourself.

Contact your healthcare provider promptly if you experience unusual changes in your mood, thoughts, or behavior.

Family members or caregivers may also help identify concerning changes during treatment.

Seek emergency medical assistance if you feel at immediate risk of harming yourself. In Canada, you can also call or text 988 for suicide crisis support.

Kidney Problems

Tenofovir disoproxil fumarate, one of the active ingredients in efavirenz/emtricitabine/tenofovir, may affect kidney function.

In some people, tenofovir can cause new or worsening kidney problems, including kidney damage that affects the body’s ability to remove waste products and maintain normal mineral levels.

The risk may be higher in people who already have kidney disease, have reduced kidney function, or take other medications that can affect the kidneys.

Tell your healthcare provider if you have a history of kidney disease, abnormal kidney function tests, or other conditions that may affect your kidneys.

Your healthcare provider may recommend blood and urine tests before treatment and periodically afterward.

These tests may include measurements of kidney function, urine protein, and urine glucose.

Contact your healthcare provider if you notice:

  • A significant decrease in urination.
  • Unusual swelling in your feet, ankles, or legs.
  • Persistent muscle weakness.
  • Unexplained tiredness.
  • New or worsening bone pain.

Because efavirenz/emtricitabine/tenofovir contains fixed doses of three medications, it may not be suitable for people who require individual dose adjustments because of reduced kidney function.

Your healthcare provider may recommend another HIV treatment if your kidney function is significantly impaired.

Bone Loss and Fracture Risk

Long-term use of tenofovir disoproxil fumarate may be associated with reduced bone mineral density.

Bone mineral density refers to the amount of minerals, including calcium, present in your bones. When bone density decreases, bones may become weaker and more likely to fracture.

In some patients, tenofovir may also affect kidney function in ways that interfere with normal bone mineral balance.

Possible bone-related concerns include:

  • Reduced Bone Density: Your bones may gradually lose mineral content.
  • Osteoporosis: People with osteoporosis may be at increased risk of fractures.
  • Bone Pain: Some people may experience persistent or unexplained bone discomfort.
  • Increased Fracture Risk: Weakened bones may become more susceptible to fractures, particularly in people with additional risk factors.

Tell your healthcare provider if you have a history of osteoporosis, bone fractures, vitamin D deficiency, or other conditions affecting bone strength.

Your healthcare provider may recommend a bone density test if you have a history of fractures or other significant risk factors for bone loss.

They may also recommend appropriate nutrition, physical activity, and other measures to support bone health.

Contact your healthcare provider if you develop persistent bone pain, muscle weakness, or an unexplained fracture.

Immune Reconstitution Inflammatory Syndrome (IRIS)

When you begin effective HIV treatment, your immune system may gradually become stronger as the amount of HIV in your blood decreases.

In some people, this improvement can trigger an inflammatory response against infections that were already present in the body.

This condition is called immune reconstitution inflammatory syndrome (IRIS).

IRIS can occur when your recovering immune system begins recognizing and responding to infections that previously caused few or no symptoms.

Examples include certain tuberculosis infections, fungal infections, and other opportunistic infections.

Possible symptoms depend on the underlying infection but may include fever, swollen lymph nodes, worsening cough, breathing difficulties, or inflammation in different parts of the body.

IRIS does not necessarily mean your HIV medication is failing. In many cases, it occurs because your immune system is recovering and becoming more active.

Contact your healthcare provider promptly if you develop new or worsening symptoms after starting treatment.

Your healthcare provider will determine whether you need additional tests or medication to manage the underlying infection or inflammation.

Drug Interactions

Efavirenz/emtricitabine/tenofovir can interact with many medications, including prescription drugs, over-the-counter products, vitamins, and herbal supplements.

Some interactions may increase the amount of medication in your bloodstream, raising your risk of side effects.

Other interactions may reduce antiretroviral drug levels, making your HIV treatment less effective and potentially increasing the risk of drug resistance.

Efavirenz affects certain liver enzymes responsible for processing medications. This means it can change how some medicines work in your body.

Examples of medications and products that require particular attention include certain:

  • Antifungal medications: Some treatments for fungal infections may interact with efavirenz.
  • Seizure medications: Drugs such as carbamazepine, phenytoin, and phenobarbital may affect treatment.
  • Tuberculosis medications: Rifampin and related medications may require special consideration.
  • Heart rhythm medications: Certain combinations may increase the risk of abnormal heart rhythms.
  • Other HIV medications: Some antiretroviral combinations may lead to significant interactions.
  • Herbal supplements: St. John’s wort can reduce efavirenz levels and should not be used with this combination.

Certain medications should not be taken with efavirenz/emtricitabine/tenofovir because the interactions can be serious.

Tell your healthcare provider and pharmacist about everything you take, including products that you use only occasionally.

Do not start, stop, or change another medication without checking whether it is safe to use with your HIV treatment.

Cardiovascular Health

People living with HIV may have an increased risk of cardiovascular disease because of several factors, including chronic inflammation, traditional cardiovascular risk factors, and the effects of certain medications.

Some studies have also raised concerns about the possible cardiovascular effects of particular antiretroviral regimens, including some efavirenz-containing treatments.

However, this does not mean that everyone taking evafereniz/emtricitabine/tenofovir will develop heart problems, and the relationship between individual HIV medications and cardiovascular risk can be complex.

Efavirenz may affect cholesterol and triglyceride levels in some patients, making regular monitoring important.

Tell your healthcare provider if you have:

  • Heart disease: Including coronary artery disease or a history of heart attack.
  • High blood pressure: A condition that increases strain on your heart and blood vessels.
  • High cholesterol: Elevated cholesterol or triglyceride levels may increase cardiovascular risk.
  • Diabetes: High blood sugar can damage blood vessels over time.
  • A history of smoking: Smoking is an important risk factor for heart disease.

Your healthcare provider may recommend monitoring your blood pressure, cholesterol, blood sugar, and other cardiovascular risk factors during treatment.

Maintaining a balanced diet, staying physically active, avoiding smoking, and managing existing medical conditions can also help support heart health.

Do not stop HIV treatment because of concerns about cardiovascular risk. Speak with your healthcare provider about whether your current regimen is appropriate for your individual health needs.

When to Contact Your Healthcare Provider

Contact your healthcare provider if you develop unusual or persistent symptoms while taking Efavirenz/emtricitabine/tenofovir, including worsening depression, persistent nausea, unexplained tiredness, muscle weakness, bone pain, or changes in urination.

You should also seek medical advice if you experience yellowing of your skin or eyes, dark urine, unexplained swelling, or new symptoms after starting HIV treatment.

Seek emergency medical attention immediately if you develop severe breathing difficulties, symptoms of lactic acidosis, a serious allergic reaction, severe psychiatric symptoms, or thoughts of self-harm that place you in immediate danger.

Continue attending regular medical appointments so your healthcare provider can monitor your viral load, kidney function, liver health, and overall response to treatment.

Always take efavirenz/emtricitabine/tenofovir exactly as prescribed. Consistent treatment, regular laboratory monitoring, and early reporting of unusual symptoms can help control HIV infection while reducing the risk of serious complications.

Is efavirenz/emtricitabine/tenofovir safe during pregnancy?

Efavirenz/Emtricitabine/Tenofovir may be used during pregnancy when your healthcare provider determines that it is an appropriate treatment for your HIV infection. If you are pregnant, planning to become pregnant, or think you might be pregnant, speak with your healthcare provider before starting or changing this medication. Efavirenz/emtricitabine/tenofovir contains three antiretroviral medications that work together to control HIV-1 infection. Although efavirenz was previously associated with concerns about birth defects, more recent pregnancy safety data have not shown an increased overall risk of birth defects from exposure during the first trimester. However, your healthcare provider will still carefully consider your medical history, viral load, previous HIV treatments, and possible medication interactions before recommending a treatment plan. Maintaining effective HIV treatment during pregnancy is extremely important. When HIV is not properly controlled, the virus can affect your health and increase the risk of transmission to your baby during pregnancy or delivery. Taking antiretroviral medication consistently can help lower your viral load and significantly reduce the risk of HIV transmission to your baby. If you become pregnant while taking efavirenz/emtricitabine/tenofovir, contact your healthcare provider promptly. Do not stop taking your medication without medical advice, as interrupting treatment may cause your viral load to increase. Your healthcare provider may recommend regular blood tests, viral load monitoring, and additional prenatal appointments to help protect your health and support a healthy pregnancy. 

Can evafereniz/emptricitabine/tenofovir cause liver damage?

Yes, efavirenz/emtricitabine/tenofovir can sometimes cause liver problems, although serious liver damage is uncommon. Your liver helps process medications and remove substances from your body. In some people, antiretroviral medications may cause liver inflammation, elevated liver enzymes, or, in rare cases, severe liver injury. The risk may be higher if you already have liver disease, hepatitis B, hepatitis C, or another condition that affects liver function. Contact your healthcare provider immediately if you experience symptoms of liver problems, including yellowing of your skin or eyes (jaundice), dark urine, persistent nausea or vomiting, loss of appetite, unusual tiredness, or pain in the upper right side of your abdomen. Your healthcare provider may recommend liver function tests before starting treatment and periodically while you are taking the medication. These tests help identify changes in liver health, sometimes before noticeable symptoms develop. If you have both HIV and hepatitis B, stopping evairenz/emtricitabine/tenofovir may cause a serious worsening of your hepatitis B infection. This is because emtricitabine and tenofovir also work against hepatitis B. Do not stop taking efavirenz/emtricitabine/tenofovir without consulting your healthcare provider. If treatment needs to be changed, your healthcare provider will determine how to manage both infections safely.

What should I do if I miss a dose of efavirenz/emtricitabine/tenofovir?

If you forget to take a dose of efavirenz/emtricitabine/tenofovir, take it as soon as you remember, unless it is almost time for your next scheduled dose. If your next dose is approaching, skip the missed tablet and continue with your regular once-daily dosing schedule. Do not take two tablets at the same time or double your next dose to make up for a missed tablet. Taking extra medication may increase your risk of side effects without improving HIV control. Efavirenz/emtricitabine/tenofovir is usually taken once daily on an empty stomach, preferably at bedtime. Try to take it at approximately the same time every day to maintain consistent medication levels in your body. Taking your medication regularly is essential because missing doses can allow HIV to multiply again, causing your viral load to increase. Repeated missed doses may also increase the risk of HIV developing resistance to one or more of the medications. Drug-resistant HIV can be more difficult to treat and may limit future treatment options. If you frequently forget doses, consider using a daily alarm, medication reminder app, or another routine that helps you remember your treatment. Contact your healthcare provider or pharmacist if you are unsure what to do after missing a dose, particularly if you have missed several doses in a row.

How long will I need to take efavirenz/emtricitabine/tenofovir?

Efavirenz/emtricitabine/tenofovir is prescribed for the long-term treatment of HIV-1 infection. Most people living with HIV need to take antiretroviral medication every day on an ongoing basis to keep the virus under control. HIV is a chronic infection that currently has no widely available cure. Although effective treatment can reduce the amount of HIV in your blood to undetectable levels, the virus remains present in your body. Taking efavirenz/emtricitabine/tenofovir consistently helps maintain viral suppression, protect your immune system, and reduce the risk of HIV-related complications. The length of time you will remain on this specific medication depends on how well it controls your HIV, whether you experience side effects, and whether other treatments become more appropriate. Your healthcare provider will monitor your viral load, CD4 cell count, kidney function, liver health, and overall response to treatment during regular medical appointments. If your HIV remains well controlled, you may continue taking this medication for many years. However, your healthcare provider may recommend switching to another antiretroviral regimen if you experience side effects, develop resistance, or need a treatment better suited to your medical needs. Do not stop taking efavirenz/emtricitabine/tenofovir without medical advice, even if you feel healthy or your viral load is undetectable. Stopping treatment can allow HIV to multiply again and may increase the risk of drug resistance.

Can I drink alcohol while taking efavirenz/emtricitabine/tenofovir?

Alcohol may increase certain side effects of efavirenz/emtricitabine/tenofovir, particularly those associated with efavirenz. Efavirenz can sometimes cause dizziness, drowsiness, difficulty concentrating, impaired coordination, and unusual dreams. Drinking alcohol may make these symptoms more noticeable and increase your risk of accidents or falls. Alcohol can also affect your judgment and memory, making it easier to forget your medication or miss scheduled doses. Drinking heavily may place additional strain on your liver, especially if you have hepatitis B, hepatitis C, or another liver condition. For these reasons, limiting or avoiding alcohol is generally advisable while taking efavirenz/emtricitabine/tenofovir, particularly when you first start treatment or experience nervous system side effects. If you choose to drink alcohol, speak with your healthcare provider about whether it is appropriate for you and what level of consumption may be lower risk based on your health. Avoid drinking alcohol if you are experiencing significant dizziness, drowsiness, or impaired coordination. Do not drive or operate machinery if alcohol or your medication affects your alertness. Continue taking your HIV medication exactly as prescribed, and do not skip or delay doses because you have consumed alcohol. If you regularly drink large amounts of alcohol, tell your healthcare provider. They can help you assess potential risks, protect your liver health, and maintain consistent HIV treatment. 

REVIEWS

Additional Information Book
Generic name:

Efavirenz/Emtricitabine/Tenofovir

Formulation:

Tablet

Strength(s):

600/200/300mg

Quantities Available:

30, 90

Why customers love Online Pharmacies Canada

Our online Canadian Pharmacy is known for high standards of quality, safety, and efficiency when it comes to medications.

Our pharmacy offers lower prices on prescription drugs compared to traditional pharmacies.

How to Order

How much Efavirenz/Emtricitabine/Tenofovir can I order at once from a Canadian pharmacy?

When ordering Efavirenz/Emtricitabine/Tenofovir from a Canadian pharmacy, you can typically purchase up to a 90-day supply at one time, which is common for prescription medications to ensure adequate management of chronic conditions without frequent refills.

Here’s what you need to know:

Dosage and Quantity: Efavirenz/Emtricitabine/Tenofovir is commonly prescribed as a fixed-dose combination pill containing 600 mg of efavirenz, 200 mg of emtricitabine, and 300 mg of tenofovir, taken once daily. For a 90-day supply, this means you would order 90 tablets (90 days x 1 tablet per day).

Do you sell efavirenz/emtricitabine/tenofovir?

Yes, we sell efavirenz/emtricitabine/tenofovir on our website. You can enjoy low prices when you order through us. To purchase efavirenz/emtricitabine/tenofovir, you will need a valid prescription from your healthcare provider. We require this prescription to dispense the medication safely and appropriately. You can submit your prescription by mailing it to us, faxing it, or uploading it through your online account.

Do you offer shipping of Efavirenz/Emtricitabine/Tenofovir (efavirenz/emtricitabine/tenofovir) to the United States?

Yes, we ship Efavirenz/Emtricitabine/Tenofovir (efavirenz/emtricitabine/tenofovir) to both the United States and Puerto Rico.

Discover Our Users' Stories!

Watch how Online Pharmacies Canada is helping customers save money on their medications.

Online Pharmacies Canada Customer Testimonial #4
Online Pharmacies Canada Customer Testimonial #1
Online Pharmacies Canada - Customer Testimonial #2

Online Pharmacies Canada has provided information from third parties intended to increase awareness and does not contain all the information about Efavirenz/Emtricitabine/Tenofovir (Efavirenz/Emtricitabine/Tenofovir). Talk to your doctor or other qualified medical practitioners for medical attention or advice, or if you have any concerns about Efavirenz/Emtricitabine/Tenofovir (Efavirenz/Emtricitabine/Tenofovir).